Identification of a Novel KIF5B-RET, ABHD17C-RET Double-Fusion Variant in Lung Adenocarcinoma and Response to Cabozantinib

J Thorac Oncol. 2020 Aug;15(8):e132-e133. doi: 10.1016/j.jtho.2019.12.114.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adenocarcinoma of Lung / drug therapy
  • Adenocarcinoma of Lung / genetics
  • Anilides / therapeutic use
  • Humans
  • Lung Neoplasms* / drug therapy
  • Lung Neoplasms* / genetics
  • Oncogene Proteins, Fusion
  • Proto-Oncogene Proteins c-ret
  • Pyridines / therapeutic use

Substances

  • Anilides
  • KIF5B-RET fusion protein, human
  • Oncogene Proteins, Fusion
  • Pyridines
  • cabozantinib
  • Proto-Oncogene Proteins c-ret
  • RET protein, human